Product Information
VENLAFAXINE HCL ER 150 MG CAP is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1333 per EA under NDC 33342019607. Its NADAC has been published 289 times since Feb 12, 2020.
Strength
150 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342019607
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
8/20/2025
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204889On Market Since
10/6/2017
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 150 MG CAP has been published 289 times since Feb 12, 2020, and over the history we have for it it has declined 26.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1333 per EA |
|---|---|
| All-time high | $0.2086 (Aug 11, 2021) |
| All-time low | $0.1057 (Nov 20, 2024) |
| 52-week high | $0.1341 |
| 52-week low | $0.1329 |
| Median price | $0.1558 |
| Average price | $0.1587 |
| Largest weekly change | +21.6% (Aug 21, 2024) |
| Weeks tracked | 289 |
| Tracking since | Feb 12, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Venlafaxine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 150 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 150 MG CAP, manufactured by Macleods Pharmaceuticals Limited, is $0.1333 per EA (NDC 33342019607), effective Aug 20, 2025.
How has the price of VENLAFAXINE HCL ER 150 MG CAP changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 150 MG CAP has declined 26.8%. It has been tracked across 289 weekly CMS publications since Feb 12, 2020.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 150 MG CAP?
Since Feb 12, 2020, the NADAC for VENLAFAXINE HCL ER 150 MG CAP has ranged from a low of $0.1057 (Nov 20, 2024) to a high of $0.2086 (Aug 11, 2021), with a median of $0.1558 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 150 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of VENLAFAXINE HCL ER 150 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures VENLAFAXINE HCL ER 150 MG CAP?
VENLAFAXINE HCL ER 150 MG CAP (NDC 33342019607) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification